Detalhe da pesquisa
1.
Outcomes of upfront autologous hematopoietic cell transplantation in patients with multiple myeloma who are 75 years old or older.
Cancer
; 127(22): 4233-4239, 2021 11 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34374445
2.
Propylene Glycol-Free Melphalan versus PG-Melphalan as Conditioning for Autologous Hematopoietic Cell Transplantation for Myeloma.
Biol Blood Marrow Transplant
; 26(12): 2229-2236, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32920204
3.
Utilization and Cost Implications of Hematopoietic Progenitor Cells Stored for a Future Salvage Autologous Transplantation or Stem Cell Boost in Myeloma Patients.
Biol Blood Marrow Transplant
; 26(11): 2011-2017, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32717431
4.
Relapse after Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma: Survival Outcomes and Factors Influencing Them.
Biol Blood Marrow Transplant
; 26(7): 1288-1297, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32135202
5.
Fludarabine/Busulfan Conditioning-Based Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: Role of Ruxolitinib in Improving Survival Outcomes.
Biol Blood Marrow Transplant
; 26(5): 893-901, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31982543
6.
Severity of Cytokine Release Syndrome and Its Association with Infections after T Cell-Replete Haploidentical Related Donor Transplantation.
Biol Blood Marrow Transplant
; 26(9): 1670-1678, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32562858
7.
Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 26(10): 1876-1885, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32653622
8.
Association of adverse events and associated cost with efficacy for approved relapsed and/or refractory multiple myeloma regimens: A Bayesian network meta-analysis of phase 3 randomized controlled trials.
Cancer
; 126(12): 2791-2801, 2020 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32154922
9.
Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma.
Cancer
; 126(23): 5077-5087, 2020 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32965680
10.
Efficacy, Toxicity, and Infectious Complications in Ruxolitinib-Treated Patients with Corticosteroid-Refractory Graft-versus-Host Disease after Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(8): 1689-1694, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30965140
11.
Outcomes of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Performed in the Inpatient versus Outpatient Setting.
Biol Blood Marrow Transplant
; 25(4): 827-833, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30572109
12.
Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.
Biol Blood Marrow Transplant
; 25(4): 699-711, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30423480
13.
Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.
Haematologica
; 104(4): 844-854, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30381298
14.
Survival of Lymphoma Patients Experiencing Relapse or Progression after an Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 24(5): 983-988, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29410340
15.
Payment and Care for Hematopoietic Cell Transplantation Patients: Toward a Specialized Medical Home for Complex Care Patients.
Biol Blood Marrow Transplant
; 24(1): 4-12, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28963077
16.
Peripheral Blood Grafts for T Cell-Replete Haploidentical Transplantation Increase the Incidence and Severity of Cytokine Release Syndrome.
Biol Blood Marrow Transplant
; 24(8): 1664-1670, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29680516
17.
Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation.
Biol Blood Marrow Transplant
; 23(8): 1295-1302, 2017 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-28412518
18.
Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report.
Cancer
; 123(16): 3141-3149, 2017 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28472539
19.
Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study.
Br J Haematol
; 179(5): 781-789, 2017 12.
Artigo
Inglês
| MEDLINE | ID: mdl-28980314
20.
Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma-a "real world" study.
Hematol Oncol
; 35(4): 528-535, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-28066928